|
|
Exchange: |
OTC Bulletin Board |
Security
Type: |
Common |
Shares
Out: |
98,530,000 |
Market
Cap: |
18.88(M) |
Last
Volume: |
78,874 |
Avg
Vol: |
78,239 |
52
Week Range: |
$0.1916 - $0.1916 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Abeona Therapeutics is a clinical-stage biopharmaceutical company developing cell and gene therapies for life-threatening rare genetic diseases. Co.'s primary clinical program is EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa, which is in the pivotal Phase 3 VIITAL clinical trial. Co. is developing additional adeno-associated virus (AAV)-based gene therapies designed to treat ophthalmic and other diseases and AAV-based gene therapies using the AIM capsid platform that Co. has licensed from University of North Carolina at Chapel Hill, and internal AAV vector research programs.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
88,758 |
Total Buy Value |
$0 |
$0 |
$0 |
$346,094 |
Total People Bought |
0 |
0 |
0 |
5 |
Total Buy Transactions |
0 |
0 |
0 |
9 |
Total Shares Sold |
113,941 |
121,941 |
121,941 |
214,793 |
Total Sell Value |
$711,341 |
$753,261 |
$753,261 |
$1,164,133 |
Total People Sold |
4 |
4 |
4 |
8 |
Total Sell Transactions |
6 |
8 |
8 |
17 |
End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Vazzano Joseph Walter |
Chief Financial Officer |
|
2025-06-06 |
4 |
S |
$6.76 |
$120,294 |
D/D |
(17,795) |
491,246 |
|
- |
|
Omalley Brendan M. |
SVP, General Counsel |
|
2025-06-06 |
4 |
S |
$6.76 |
$70,777 |
D/D |
(10,470) |
378,245 |
|
- |
|
Seshadri Vishwas |
Chief Executive Officer |
|
2025-06-06 |
4 |
S |
$6.76 |
$342,570 |
D/D |
(50,676) |
1,303,761 |
|
- |
|
Vazzano Joseph Walter |
Chief Financial Officer |
|
2025-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
13,333 |
504,579 |
|
- |
|
Seshadri Vishwas |
Chief Executive Officer |
|
2025-06-01 |
4 |
D |
$6.24 |
$5,522 |
D/D |
(885) |
1,354,437 |
|
- |
|
Alvino Mark |
Director |
|
2025-05-27 |
4 |
S |
$6.38 |
$12,760 |
D/D |
(2,000) |
90,435 |
|
- |
|
Alvino Mark |
Director |
|
2025-05-16 |
4 |
S |
$5.68 |
$45,440 |
D/D |
(8,000) |
92,435 |
|
- |
|
Seshadri Vishwas |
Chief Executive Officer |
|
2025-03-31 |
4 |
AS |
$4.78 |
$119,500 |
D/D |
(25,000) |
1,355,322 |
|
- |
|
Vazzano Joseph Walter |
Chief Financial Officer |
|
2025-03-14 |
4 |
D |
$5.29 |
$3,624 |
D/D |
(685) |
509,041 |
|
- |
|
Omalley Brendan M. |
SVP, General Counsel |
|
2025-03-03 |
4 |
D |
$5.24 |
$948 |
D/D |
(181) |
388,715 |
|
- |
|
Zeiher Bernhardt G |
Director |
|
2025-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
36,101 |
47,145 |
|
- |
|
Wuchterl Donald A. |
Director |
|
2025-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
36,101 |
150,612 |
|
- |
|
Alvino Mark |
Director |
|
2025-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
36,101 |
100,435 |
|
- |
|
Charles Faith L. |
Director |
|
2025-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
36,101 |
149,832 |
|
- |
|
Alland Leila |
Director |
|
2025-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
36,101 |
154,366 |
|
- |
|
Amoroso Michael |
Director |
|
2025-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
36,101 |
180,466 |
|
- |
|
Silverstein Christine Berni |
Director |
|
2025-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
36,101 |
133,572 |
|
- |
|
Crombez Eric |
Director |
|
2025-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
36,101 |
47,145 |
|
- |
|
Alvino Mark |
Director |
|
2025-01-29 |
4 |
S |
$5.38 |
$21,520 |
D/D |
(4,000) |
64,334 |
|
- |
|
Seshadri Vishwas |
Chief Executive Officer |
|
2025-01-21 |
4 |
A |
$0.00 |
$0 |
D/D |
476,435 |
1,380,322 |
|
- |
|
Omalley Brendan M. |
SVP, General Counsel |
|
2025-01-21 |
4 |
A |
$0.00 |
$0 |
D/D |
115,607 |
388,896 |
|
- |
|
Vazzano Joseph Walter |
Chief Financial Officer |
|
2025-01-21 |
4 |
A |
$0.00 |
$0 |
D/D |
144,509 |
509,726 |
|
- |
|
Alvino Mark |
Director |
|
2025-01-21 |
4 |
S |
$5.10 |
$20,400 |
D/D |
(4,000) |
68,334 |
|
- |
|
Seshadri Vishwas |
Chief Executive Officer |
|
2024-10-16 |
4 |
D |
$6.54 |
$1,642 |
D/D |
(251) |
903,887 |
|
- |
|
Omalley Brendan M. |
SVP, General Counsel |
|
2024-09-28 |
4 |
D |
$5.89 |
$38,750 |
D/D |
(6,579) |
273,289 |
|
- |
|
196 Records found
|
|
Page 1 of 8 |
|
|